Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and management

A Tefferi, T Barbui - American journal of hematology, 2023 - Wiley Online Library
Abstract Disease Overview Polycythemia vera (PV) is a JAK2‐mutated myeloproliferative
neoplasm characterized by clonal erythrocytosis; other features include leukocytosis …

Testosterone therapy-induced erythrocytosis: can phlebotomy be justified?

P Bond, T Verdegaal, DL Smit - Endocrine Connections, 2024 - ec.bioscientifica.com
Erythrocytosis, or elevated hematocrit, is a common side effect of testosterone therapy (TTh)
in male hypogonadism. Testosterone stimulates erythropoiesis through an initial rise in …

Erythrocytosis: Diagnosis and investigation

I Noumani, CN Harrison… - International Journal of …, 2024 - Wiley Online Library
An absolute erythrocytosis is present when the red cell mass is greater than 125% of the
predicted. This is suspected when the hemoglobin or hematocrit is above the normal range …

Sodium–glucose co-transporter-2 inhibitor use and erythrocytosis: assessment of risk and need for referral to haematology

N Gangat, A Tefferi - Nephrology Dialysis Transplantation, 2023 - academic.oup.com
Sodium–glucose co-transporter-2 inhibitors(SGLT2is; canagliflozin, empagliflozin,
dapagliflozin, ertugliflozin and sotagliflozin), also referred to as 'gliflozins', are US Food and …

Testosterone-induced erythrocytosis in transgender males: challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications …

A Mohammed, YH Mamoojee, R Quinton - Best Practice & Research …, 2024 - Elsevier
Testosterone-induced erythrocytosis in transgender males: challenges arising from an
increasing prevalence of metabolic syndrome and wider therapeutic indications for …

Erythrocytosis and CKD

M Aoun, M Jadoul, HJ Anders - American Journal of Kidney Diseases, 2024 - Elsevier
Erythrocytosis or polycythemia is defined as an increase in red blood cell concentration
above the age-and sex-specific normal levels. Unlike anemia that is very common in chronic …

Zebrafish mutants in egln1 display a hypoxic response and develop polycythemia

X Dou, Z Chen, Y Liu, Y Li, J Ye, L Lu - Life Sciences, 2024 - Elsevier
Aims Prolyl hydroxylase domain 2 (PHD2), encoded by the Egln1 gene, serves as a pivotal
regulator of the hypoxia-inducible factor (HIF) pathway and acts as a cellular oxygen sensor …

Predictors of Progression in a Series of 81 Adult Patients Surgically Managed for an Intracranial Hemangioblastoma: Implications for the Postoperative Follow-Up

E Garrido, HL Ngoc, J Guyotat, I Pelissou-Guyotat… - Cancers, 2024 - mdpi.com
Simple Summary Local or distant progression is possible after the resection of an
intracranial hemangioblastoma. Few studies have focused on predictors of …

Gender-affirming hormone therapy in the transgender patient: influence on thrombotic risk

H King, TP Kelley, JJ Shatzel - Hematology, 2024 - ashpublications.org
Research regarding the hematologic sequelae of estrogen and testosterone therapy for
transgender people is an emerging area. While estrogen therapy has been widely studied in …

[HTML][HTML] TNF-α is a predictive marker in distinguishing myeloproliferative neoplasm and idiopathic erythrocytosis/thrombocytosis: development and validation of a non …

Z Wang, Y Mei, Z Yang, Q Gao, H Xu, Z Han… - Frontiers in …, 2024 - frontiersin.org
Purpose Philadelphia-chromosome negative myeloproliferative neoplasms (MPN) exhibit
phenotypic similarities with JAK/STAT-unmutated idiopathic erythrocytosis and …